MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC.
IEX Last Trade
5.46
-0.005 -0.092%
Share volume: 9,859
Last Updated: Fri 27 Dec 2024 08:30:26 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$5.46
0.00
-0.09%
Fundamental analysis
24%
Profitability
14%
Dept financing
23%
Liquidity
75%
Performance
20%
Performance
5 Days
9.36%
1 Month
-5.24%
3 Months
-33.37%
6 Months
-20.76%
1 Year
-15.77%
2 Year
-59.41%
Key data
Stock price
$5.46
DAY RANGE
$5.38 - $5.60
52 WEEK RANGE
$4.65 - $11.55
52 WEEK CHANGE
-$14.35
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Carl W. Hull
Region: US
Website: maravai.com
Employees: 610
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: maravai.com
Employees: 610
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Maravai LifeSciences Holdings, Inc. provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics.
Recent news